Detalhe da pesquisa
1.
SOX11 augments BCR signaling to drive MCL-like tumor development.
Blood
; 131(20): 2247-2255, 2018 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-29615403
2.
SOX11 Inhibitors Are Cytotoxic in Mantle Cell Lymphoma.
Clin Cancer Res
; 27(16): 4652-4663, 2021 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34158358
3.
Design, synthesis and evaluation of (E)-alpha-benzylthio chalcones as novel inhibitors of BCR-ABL kinase.
Bioorg Med Chem
; 18(6): 2317-2326, 2010 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20188579
4.
Myeloma CAR-T CRS Management With IL-1R Antagonist Anakinra.
Clin Lymphoma Myeloma Leuk
; 20(9): 632-636.e1, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32553791
5.
Conformational analysis of the GTP-binding protein MxA using limited proteolysis.
FEBS Lett
; 516(1-3): 129-32, 2002 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-11959118
6.
Jak/STAT pathways in cytokine signaling and myeloproliferative disorders: approaches for targeted therapies.
Genes Cancer
; 1(10): 979-93, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21442038
7.
A Non-ATP-Competitive Dual Inhibitor of JAK2 and BCR-ABL Kinases: Elucidation of a Novel Therapeutic Spectrum Based on Substrate Competitive Inhibition.
Genes Cancer
; 1(4): 331-45, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20717479
8.
Expression of the antiviral protein MxA in cells transiently perturbs endocytosis.
Biochem Biophys Res Commun
; 323(2): 541-6, 2004 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15369785
9.
Dynamin interacts with members of the sumoylation machinery.
J Biol Chem
; 279(30): 31445-54, 2004 Jul 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-15123615